{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:43:38Z","timestamp":1754145818273,"version":"3.41.2"},"reference-count":10,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,17]]},"DOI":"10.1182\/blood.2025029715","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:32:00Z","timestamp":1752766320000},"page":"263-265","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Weathering the HLH storm and redesigning clinical trials"],"prefix":"10.1182","volume":"146","author":[{"given":"Adi","family":"Zoref-Lorenz","sequence":"first","affiliation":[{"name":"1Meir Medical Center"},{"name":"2Cincinnati Children\u2019s Hospital Medical Center"},{"name":"3Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6804-1472","authenticated-orcid":false,"given":"Martin","family":"Ellis","sequence":"additional","affiliation":[{"name":"1Meir Medical Center"},{"name":"3Tel Aviv University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"3","key":"2025071711315308000_bib1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood.2024026139","article-title":"Ruxolitinib combined with dexamethasone for adult patients with newly diagnosed hemophagocytic lymphohistiocytosis in China","volume":"146","author":"Zhou","year":"2025","journal-title":"Blood"},{"issue":"2","key":"2025071711315308000_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2025071711315308000_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/hematology.2023000509","article-title":"Inpatient recognition and management of HLH","volume":"2023","author":"Zoref-Lorenz","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"13","key":"2025071711315308000_bib4","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2025071711315308000_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2025071711315308000_bib6","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol"},{"issue":"6","key":"2025071711315308000_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.2020006075","article-title":"JAK\/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation","volume":"136","author":"Meyer","year":"2020","journal-title":"Blood"},{"issue":"3","key":"2025071711315308000_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.hoc.2025.02.007","article-title":"Recognizing and managing secondary hemophagocytic lymphohistiocytosis in adults: a practical clinical guide","volume":"39","author":"Zoref-Lorenz","year":"2025","journal-title":"Hematol Oncol Clin North Am"},{"key":"2025071711315308000_bib9","doi-asserted-by":"crossref","first-page":"20406207241245517","DOI":"10.1177\/20406207241245517","article-title":"Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study","volume":"15","author":"Lee","year":"2024","journal-title":"Ther Adv Hematol"},{"issue":"4","key":"2025071711315308000_bib10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/10428194.2024.2436037","article-title":"Malignancy-associated HLH: mechanisms, diagnosis, and treatment of a severe hyperinflammatory syndrome","volume":"66","author":"Zoref-Lorenz","year":"2025","journal-title":"Leuk Lymphoma"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/3\/263\/2403205\/blood_bld-2025-029715-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/146\/3\/263\/2403205\/blood_bld-2025-029715-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T15:32:01Z","timestamp":1752766321000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/146\/3\/263\/546108\/Weathering-the-HLH-storm-and-redesigning-clinical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025029715","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,17]]},"published":{"date-parts":[[2025,7,17]]}}}